| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |